Chronic Kidney Disease Clinical Trials in Philadelphia, Pennsylvania

7 studies are recruiting for chronic kidney disease in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

   Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine. The kidneys filter waste and fluid from the blood to form urine. In children wit…

   Stage

   Phase 3

   Ages

   1 to 18

   Site

   Children's Hospital of Philadelphia - Nephrology, Philadelphia, Pennsylvania

   Locations

   151 in total

   Run by

   Bayer

   See if you can join NCT05457283 on ClinicalTrials.gov

2. A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

   This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in chil…

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

   Locations

   93 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07107945 on ClinicalTrials.gov

3. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

   This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, Philadelphia, Pennsylvania

   Locations

   715 in total

   Run by

   AstraZeneca

   See if you can join NCT07753993 on ClinicalTrials.gov

4. Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

   The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Bloo…

   Stage

   Not phased

   Ages

   0 to 22

   Site

   The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

   Locations

   2 in total

   Run by

   Johns Hopkins Bloomberg School of Public Health

   See if you can join NCT00327860 on ClinicalTrials.gov

5. Transforming Hemodialysis-Related Vascular Access Education

   The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   3 in total

   Run by

   University of Pennsylvania

   See if you can join NCT05997875 on ClinicalTrials.gov

6. A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

   This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.

   Stage

   Phase 3

   Ages

   0 to 18

   Site

   Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania

   Locations

   43 in total

   Run by

   Amgen

   See if you can join NCT03633708 on ClinicalTrials.gov

7. Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

   Chronic kidney disease (CKD) affects approximately 26 million Americans and disproportionately manifests in specific race and ethnic groups. Patients burdened with CKD have significant morbidity and reduced life expectancy. In addition to excessive suffering and lost productivity, the cost of manag…

   Stage

   Not phased

   Ages

   Any age

   Site

   Temple University, Philadelphia, Pennsylvania

   Locations

   5 in total

   Run by

   University of Michigan

   See if you can join NCT01016613 on ClinicalTrials.gov